Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MacroGenics, Inc. - Common Stock (NQ:MGNX)

3.730 -0.130 (-3.37%)
Delayed Quote Updated: 2:04 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 263,201
Open 3.850
Bid (Size) 3.730 (200)
Ask (Size) 3.740 (1,800)
Prev. Close 3.860
Today's Range 3.705 - 3.880
52wk Range 1.290 - 5.080
Shares Outstanding 61,107,288
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MacroGenics (NASDAQ:MGNX): A Minervini Trend Template High-Growth Momentum Case Study ↗
Via Chartmill
News headline image
MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
From MacroGenics, Inc.
Via GlobeNewswire

Performance

YTD
+131.7%
+131.7%
1 Month
-6.5%
-6.5%
3 Month
-19.3%
-19.3%
6 Month
+28.6%
+28.6%
1 Year
+122.0%
+122.0%

More News

Read More
News headline image
Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited. ↗
Via The Motley Fool
News headline image
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations
Via MediaOutReach
Topics Economy
News headline image
MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates ↗
Via MarketBeat
News headline image
MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
From MacroGenics, Inc.
Via GlobeNewswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MGNX Closes Up 45% On Wall Street Optimism For Experimental Cancer Therapies ↗
Via Stocktwits
Which stocks are moving on Tuesday? ↗
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
News headline image
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
MacroGenics to Participate in the Stifel 2025 Healthcare Conference
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
What's going on in today's after hours session ↗
Via Chartmill
News headline image
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Thursday's after hours session: top gainers and losers ↗
Via Chartmill

Frequently Asked Questions

Is MacroGenics, Inc. - Common Stock publicly traded?
Yes, MacroGenics, Inc. - Common Stock is publicly traded.
What exchange does MacroGenics, Inc. - Common Stock trade on?
MacroGenics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for MacroGenics, Inc. - Common Stock?
The ticker symbol for MacroGenics, Inc. - Common Stock is MGNX on the Nasdaq Stock Market
What is the current price of MacroGenics, Inc. - Common Stock?
The current price of MacroGenics, Inc. - Common Stock is 3.730
When was MacroGenics, Inc. - Common Stock last traded?
The last trade of MacroGenics, Inc. - Common Stock was at 10/01/26 02:04 PM ET
What is the market capitalization of MacroGenics, Inc. - Common Stock?
The market capitalization of MacroGenics, Inc. - Common Stock is 227.93M
How many shares of MacroGenics, Inc. - Common Stock are outstanding?
MacroGenics, Inc. - Common Stock has 228M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.